683 related articles for article (PubMed ID: 35216439)
21. Polysaccharide-rich fractions from Enteromorpha prolifera improve hepatic steatosis and gut barrier integrity in high-fat diet-induced obese mice linking to modulation of gut microbiota.
Zou T; Xie F; Liang P; Chen J; Wang Z; Du M; You J
Biomed Pharmacother; 2023 Jan; 157():114034. PubMed ID: 36434956
[TBL] [Abstract][Full Text] [Related]
22. Liraglutide modulates gut microbiota and reduces NAFLD in obese mice.
Moreira GV; Azevedo FF; Ribeiro LM; Santos A; Guadagnini D; Gama P; Liberti EA; Saad M; Carvalho C
J Nutr Biochem; 2018 Dec; 62():143-154. PubMed ID: 30292107
[TBL] [Abstract][Full Text] [Related]
23. Akkermansia muciniphila improves metabolic profiles by reducing inflammation in chow diet-fed mice.
Zhao S; Liu W; Wang J; Shi J; Sun Y; Wang W; Ning G; Liu R; Hong J
J Mol Endocrinol; 2017 Jan; 58(1):1-14. PubMed ID: 27821438
[TBL] [Abstract][Full Text] [Related]
24. Propionic acid and not caproic acid, attenuates nonalcoholic steatohepatitis and improves (cerebro) vascular functions in obese Ldlr
Tengeler AC; Gart E; Wiesmann M; Arnoldussen IAC; van Duyvenvoorde W; Hoogstad M; Dederen PJ; Verweij V; Geenen B; Kozicz T; Kleemann R; Morrison MC; Kiliaan AJ
FASEB J; 2020 Jul; 34(7):9575-9593. PubMed ID: 32472598
[TBL] [Abstract][Full Text] [Related]
25. 1-Deoxynojirimycin improves high fat diet-induced nonalcoholic steatohepatitis by restoring gut dysbiosis.
Zheng J; Zhu L; Hu B; Zou X; Hu H; Zhang Z; Jiang N; Ma J; Yang H; Liu H
J Nutr Biochem; 2019 Sep; 71():16-26. PubMed ID: 31272028
[TBL] [Abstract][Full Text] [Related]
26. Vitamin D Signaling through Induction of Paneth Cell Defensins Maintains Gut Microbiota and Improves Metabolic Disorders and Hepatic Steatosis in Animal Models.
Su D; Nie Y; Zhu A; Chen Z; Wu P; Zhang L; Luo M; Sun Q; Cai L; Lai Y; Xiao Z; Duan Z; Zheng S; Wu G; Hu R; Tsukamoto H; Lugea A; Liu Z; Pandol SJ; Han YP
Front Physiol; 2016; 7():498. PubMed ID: 27895587
[TBL] [Abstract][Full Text] [Related]
27. Blocking integrin α
Rai RP; Liu Y; Iyer SS; Liu S; Gupta B; Desai C; Kumar P; Smith T; Singhi AD; Nusrat A; Parkos CA; Monga SP; Czaja MJ; Anania FA; Raeman R
J Hepatol; 2020 Nov; 73(5):1013-1022. PubMed ID: 32540177
[TBL] [Abstract][Full Text] [Related]
28. The metabolic and vascular protective effects of olive (Olea europaea L.) leaf extract in diet-induced obesity in mice are related to the amelioration of gut microbiota dysbiosis and to its immunomodulatory properties.
Vezza T; Rodríguez-Nogales A; Algieri F; Garrido-Mesa J; Romero M; Sánchez M; Toral M; Martín-García B; Gómez-Caravaca AM; Arráez-Román D; Segura-Carretero A; Micol V; García F; Utrilla MP; Duarte J; Rodríguez-Cabezas ME; Gálvez J
Pharmacol Res; 2019 Dec; 150():104487. PubMed ID: 31610229
[TBL] [Abstract][Full Text] [Related]
29. Targeting the gut microbiota with resveratrol: a demonstration of novel evidence for the management of hepatic steatosis.
Wang P; Wang J; Li D; Ke W; Chen F; Hu X
J Nutr Biochem; 2020 Jul; 81():108363. PubMed ID: 32388250
[TBL] [Abstract][Full Text] [Related]
30. Polydextrose with and without Bifidobacterium animalis ssp. lactis 420 drives the prevalence of Akkermansia and improves liver health in a multi-compartmental obesogenic mice study.
Yde CC; Jensen HM; Christensen N; Servant F; Lelouvier B; Lahtinen S; Stenman LK; Airaksinen K; Kailanto HM
PLoS One; 2021; 16(12):e0260765. PubMed ID: 34855861
[TBL] [Abstract][Full Text] [Related]
31. Impact of Vancomycin Treatment and Gut Microbiota on Bile Acid Metabolism and the Development of Non-Alcoholic Steatohepatitis in Mice.
Kasai K; Igarashi N; Tada Y; Kani K; Takano S; Yanagibashi T; Usui-Kawanishi F; Fujisaka S; Watanabe S; Ichimura-Shimizu M; Takatsu K; Tobe K; Tsuneyama K; Furusawa Y; Nagai Y
Int J Mol Sci; 2023 Feb; 24(4):. PubMed ID: 36835461
[TBL] [Abstract][Full Text] [Related]
32. Role of gut microbiota and Toll-like receptors in nonalcoholic fatty liver disease.
Miura K; Ohnishi H
World J Gastroenterol; 2014 Jun; 20(23):7381-91. PubMed ID: 24966608
[TBL] [Abstract][Full Text] [Related]
33. Increase of
Nishiyama M; Ohtake N; Kaneko A; Tsuchiya N; Imamura S; Iizuka S; Ishizawa S; Nishi A; Yamamoto M; Taketomi A; Kono T
Nutrients; 2020 Mar; 12(3):. PubMed ID: 32245128
[TBL] [Abstract][Full Text] [Related]
34. Si Miao Formula attenuates non-alcoholic fatty liver disease by modulating hepatic lipid metabolism and gut microbiota.
Han R; Qiu H; Zhong J; Zheng N; Li B; Hong Y; Ma J; Wu G; Chen L; Sheng L; Li H
Phytomedicine; 2021 May; 85():153544. PubMed ID: 33773192
[TBL] [Abstract][Full Text] [Related]
35. Red pitaya betacyanins protects from diet-induced obesity, liver steatosis and insulin resistance in association with modulation of gut microbiota in mice.
Song H; Chu Q; Yan F; Yang Y; Han W; Zheng X
J Gastroenterol Hepatol; 2016 Aug; 31(8):1462-9. PubMed ID: 26699443
[TBL] [Abstract][Full Text] [Related]
36. Longitudinal 16S rRNA Sequencing Reveals Relationships among Alterations of Gut Microbiota and Nonalcoholic Fatty Liver Disease Progression in Mice.
Zhuge A; Li S; Lou P; Wu W; Wang K; Yuan Y; Xia J; Li B; Li L
Microbiol Spectr; 2022 Jun; 10(3):e0004722. PubMed ID: 35647690
[TBL] [Abstract][Full Text] [Related]
37. Chronic calcitriol supplementation improves the inflammatory profiles of circulating monocytes and the associated intestinal/adipose tissue alteration in a diet-induced steatohepatitis rat model.
Su YB; Li TH; Huang CC; Tsai HC; Huang SF; Hsieh YC; Yang YY; Huang YH; Hou MC; Lin HC
PLoS One; 2018; 13(4):e0194867. PubMed ID: 29684027
[TBL] [Abstract][Full Text] [Related]
38. Isoxanthohumol improves obesity and glucose metabolism via inhibiting intestinal lipid absorption with a bloom of Akkermansia muciniphila in mice.
Watanabe Y; Fujisaka S; Morinaga Y; Watanabe S; Nawaz A; Hatta H; Kado T; Nishimura A; Bilal M; Aslam MR; Honda K; Nakagawa Y; Softic S; Hirabayashi K; Nakagawa T; Nagai Y; Tobe K
Mol Metab; 2023 Nov; 77():101797. PubMed ID: 37709134
[TBL] [Abstract][Full Text] [Related]
39.
Xu Y; Wang N; Tan HY; Li S; Zhang C; Zhang Z; Feng Y
Theranostics; 2020; 10(24):11302-11323. PubMed ID: 33042284
[No Abstract] [Full Text] [Related]
40. Hepatocyte MyD88 affects bile acids, gut microbiota and metabolome contributing to regulate glucose and lipid metabolism.
Duparc T; Plovier H; Marrachelli VG; Van Hul M; Essaghir A; Ståhlman M; Matamoros S; Geurts L; Pardo-Tendero MM; Druart C; Delzenne NM; Demoulin JB; van der Merwe SW; van Pelt J; Bäckhed F; Monleon D; Everard A; Cani PD
Gut; 2017 Apr; 66(4):620-632. PubMed ID: 27196572
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
